Skip to main content

AIA Group Ltd

SEC CIK
0001522877
Latest filing
Aug 13, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by AIA Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
8,736
Value
$5.45M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by AIA Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,736$5.45M0.1%+276+3.3%AddedHolders
Q1 20268,460$6.54M0.1%+1,052+14.2%AddedHolders
Q4 20257,408$5.72M0.1%−9,779−56.9%ReducedHolders
Q3 202517,187$9.66M0.2%−70−0.4%ReducedHolders
Q2 202517,257$9.06M0.2%+1,164+7.2%AddedHolders
Q1 202516,093$10.2M0.3%+2,493+18.3%AddedHolders
Q4 202413,600$9.69M0.2%+2,959+27.8%AddedHolders
Q3 202410,641$11.2M0.3%+621+6.2%AddedHolders
Q2 202410,020$10.5M0.3%+3,132+45.5%AddedHolders
Q1 20246,888$6.63M0.2%+2,166+45.9%AddedHolders
Q4 20234,722$4.15M0.2%+565+13.6%AddedHolders
Q3 20234,157$3.42M0.2%−554−11.8%ReducedHolders
Q2 20234,711$3.39M0.2%+1,077+29.6%AddedHolders
Q1 20233,634$2.99M0.2%−2,324−39.0%ReducedHolders
Q4 20225,958$4.30M0.3%−722−10.8%ReducedHolders
Q3 20226,680$4.60M0.3%+1,601+31.5%AddedHolders
Q2 20225,079$3.00M0.2%+1,845+57.1%AddedHolders
Q1 20223,234$2.26M0.1%+1,439+80.2%AddedHolders
Q4 20211,795$1.13M0.1%+696+63.3%AddedHolders
Q3 20211,099$665.0K<0.1%+385+53.9%AddedHolders
Q2 2021714$418.0K<0.1%−804−53.0%ReducedHolders
Q1 20211,518$718.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.